Chronic Kidney Disease

The Skidki-na-vse® Chronic Kidney Disease resource center provides clinical news and articles, coverage from conferences and meetings, links to condition-specific resources, and videos and other content.

What can we help you find?
[[thumbnail_alt_text]]
The oral therapy is indicated to act as both a monotherapy and a combination therapy to improve glycemic control. It is also indicated to prevent cardiovascular and renal death in patients with CKD.
[[thumbnail_alt_text]]
According to the National Institute of Diabetes and Digestive and Kidney Diseases, more than 661,000 Americans have kidney failure.
[[thumbnail_alt_text]]
According to the CDC, approximately 1 of 3 patients with type 1 and 2 diabetes mellitus (DM) has CKD. What do we need to know about patients with DM and CKD?
[[thumbnail_alt_text]]
High consumption of sugary beverages has previously been linked to obesity, diabetes, and some types of cancer.
[[thumbnail_alt_text]]
A multimethod approach including use of refill data may be the most effective method to identify nonadherence in young patients with chronic kidney disease.
[[thumbnail_alt_text]]
In an additional analysis from the CANVAS program, new data reinforce evidence of improved renal outcomes for those with type 2 diabetes and chronic kidney disease.
 
[[thumbnail_alt_text]]
Screening for HBV among high-risk populations is crucial to stopping transmission of the virus.
[[thumbnail_alt_text]]
HIV-positive patients need to maintain healthy body weight, quit smoking, eat well, exercise regularly and treat hypertension, diabetes and dyslipidemia.
[[thumbnail_alt_text]]
Direct-acting antivirals drugs show similar cure rates in co-infected patients as high as mono-infected patients.
[[thumbnail_alt_text]]
Heplisav-B is the only 2-dose hepatitis B vaccine recombinant approved in the United States.
[[thumbnail_alt_text]]
Ferric citrate was originally approved for the control of serum phosphorus levels in patients with chronic kidney disease who require dialysis.
+ Load More